Clinical Trials Directory

Trials / Completed

CompletedNCT02271646

Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation

Ultrasound Guided Thoracic Paravertebral Blocks: An Effective Pain Control in Percutaneous Radiofrequency Ablation of Hepatic Tumors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients undergo percutaneous radiofrequency ablation of hepatic tumors at Siriraj hospital normally receive only intravenous sedative drugs which sometimes can not provide effective pain control. TPVB is suitable for unilateral operations. And it is increasing popular nowadays because of using ultrasound guided which make it is more reliable and has less side effects especially the severe one such as pneumothorax. To cover all nerve supply liver, we decided to use right TPVB at T5-6, T7-8, and T9-10. The aim of this study is to prove that TPVB can provide an effective pain control for patients undergo liver RFA both at rest and movement (cough). We are going to measure the pain score at recovery room and the effective pain control means patients has mild pain (pain score less \</= 3 and do not ask for analgesic drugs).

Conditions

Interventions

TypeNameDescription
DRUG0.5% marcaine 20ml3 levels ultrasound guided thoracic paravertebral block at T5-6, T7-8 and T9-10 (total 0.5% marcaine 20ml)

Timeline

Start date
2014-08-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-10-22
Last updated
2019-03-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02271646. Inclusion in this directory is not an endorsement.